Abstract
Approximately 14 million women of child-bearing age are living with HIV/AIDS in sub-Saharan Africa. Women with HIV infection have between 25% and 40% lower fertility than noninfected women. As antiretroviral (ARV) therapy becomes increasingly accessible in sub-Saharan Africa, it is important to understand whether and how the associated clinical improvements correspond with changes in the incidence of pregnancy and fertility. Accordingly, this paper reviews the literature on the potential impact of ARV therapy on the fertility of women with HIV infection in sub-Saharan Africa. We use Bongaarts‘ proximate determinants of fertility framework (adapted for conditions of a generalized HIV epidemic) to examine the underlying mechanisms through which use of ARV therapy may impact the fertility of women with HIV infection. A conceptual framework is proposed to guide future research aimed at understanding how widespread use of ARV therapy may impact fertility in sub-Saharan Africa.
Similar content being viewed by others
References and Recommended Reading
Joint United Nations Programme on HIV/AIDS: AIDS epidemic update: December 2005. Geneva: World Health Organization; 2005.
Allen S: Why is fertility an issue for HIV-infected and at-risk women? J Acquir Immune Defic Syndr 2005, 38(Suppl 1):S1-S3.
Zaba B, Gregson S: Measuring the impact of HIV on fertility in Africa. AIDS 1998, 12(Suppl 1):S41-S45.
Lewis JJ, Ronsmans C, Ezeh A, Gregson S: The population impact of HIV on fertility in sub-Saharan Africa. AIDS 2004, 18(Suppl 2):S35-S43. A recent and updated review article measuring the impact of HIV on fertility in Africa.
WHO 2003–08: A programme of quiet thunder takes shape [editorial]. Lancet 2003, 362:179.
World Health Organization: "3 by 5" progress report. Geneva: UNAIDS/WHO; 2004.
Palella FJ Jr, Delaney KM, Moorman AC, et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998, 338:853–860.
Hogg RS, Heath KV, Yip B, et al.: Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 1998, 279:450–454.
Seyler C, Anglaret X, Dakoury-Dogbo N, et al.: Mediumterm survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Cote d‘Ivoire. Antivir Ther 2003, 8:385–393.
Wools-Kaloustian K, Kimaiyo S, Diero L, et al.: Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. AIDS 2006, 20:41–48.
Bongaarts J, Potter RG: Fertility, Biology, and Behavior: An Analysis of the Proximate Determinants. New York: Academic Press; 1983.
Boerma JT, Weir SS: Integrating demographic and epidemiological approaches to research on HIV/AIDS: the proximate-determinants framework. J Infect Dis 2005, 191(Suppl 1):S61-S67.
Fabiani M, Nattabi B, Ayella EO, et al.: Differences in fertility by HIV serostatus and adjusted HIV prevalence data from an antenatal clinic in northern Uganda. Trop Med Int Health 2006, 11:182–187.
Ross A, Van der Paal L, Lubega R: HIV-1 disease progression and fertility: the incidence of recognized pregnancy and pregnancy outcome in Uganda. AIDS 2004, 18:799–804.
Sedgh G, Larsen U, Spiegelman D, et al.: HIV-1 disease progression and fertility in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr 2005, 39:439–445.
Loko MA, Toure S, Dakoury-Dogbo N, et al.: Decreasing incidence of pregnancy by decreasing CD4 cell count in HIV-infected women in Cote d‘Ivoire: a 7-year cohort study. AIDS 2005, 19:443–445.
van Benthem BH, De Vincenzi I, Delmas MC, et al.: Pregnancies before and after HIV diagnosis in a European cohort of HIV-infected women. European Study on the Natural History of HIV Infection in Women. AIDS 2000, 14:2171–2178.
Forsyth BW, Davis JA, Freudigman KA, et al.: Pregnancy and birth rates among HIV-infected women in the United States: the confounding effects of illicit drug use. AIDS 2002, 16:471–479.
De Vincenzi I, Jadand C, Couturier E, et al.: Pregnancy and contraception in a French cohort of HIV-infected women. SEROCO Study Group. AIDS 1997, 11:333–338.
D‘Ubaldo C, Pezzotti P, Rezza G, et al.: Association between HIV-1 infection and miscarriage: a retrospective study. DIANAIDS Collaborative Study Group. AIDS 1998, 12:1087–1093.
Thackway SV, Furner V, Mijch A, et al.: Fertility and reproductive choice in women with HIV-1 infection. AIDS 1997, 11:663–667.
Hankins C, Tran T, Lapointe N: Sexual behaviour and pregnancy outcome in HIV-infected women. Canadian Women‘s HIV Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 18:479–487.
Lee LM, Wortley PM, Fleming PL, et al.: Duration of human immunodeficiency virus infection and likelihood of giving birth in a Medicaid population in Maryland. Am J Epidemiol 2000, 151:1020–1028.
Blair JM, Hanson DL, Jones JL, Dworkin MS: Trends in pregnancy rates among women with human immunode.-ciency virus. Obstet Gynecol 2004, 103:663–668. A cohort study measuring trends in incidence of pregnancy among women with HIV infection in America before and during the HAART era.
Massad LS, Springer G, Jacobson L, et al.: Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV. AIDS 2004, 18:281–286.
Fapohunda ER, Todaro MP: Family structure, implicit contracts, and the demand for children in southern Nigeria. Population and Development Review 1998, 14:571–594.
Gregson S, Zaba B, Hunter SC: The Impact of HIV-1 on Fertility in Sub-Saharan Africa: Causes and Consequences. http://www.un.org/esa/population/publications/completingfertility/ RevisedZabapaper.PDF. Accessed March 20, 2006. A review article investigating the causes and consequences of HIV on fertility in sub-Saharan Africa.
Ntozi JPM: Impact of HIV/AIDS on Fertility in Sub-Saharan Africa. http://www.uneca.org/eca_resources/ major_eca_websites/icpd/fourth/fc4-05.%20doc%20impact %20hiv%20on%20fertility.htm. Accessed April 1, 2006.
Stover J: Revising the proximate determinants of fertility framework: what have we learned in the past 20 years? Stud Fam Plann 1998, 29:255–267.
Gage AJ, Meekers D: Sexual activity before marriage in sub-Saharan Africa. Soc Biol 1994, 41:44–60.
Garenne M, Zwang J: Premarital fertility in Namibia: trends, factors and consequences. J Biosoc Sci 2006, 38:145–167.
Asiimwe-Okiror G, Opio AA, Musinguzi J, et al.: Change in sexual behaviour and decline in HIV infection among young pregnant women in urban Uganda. AIDS 1997, 11:1757–1763.
Mukiza-Gapere J, Ntozi JP: Impact of AIDS on marriage patterns, customs and practices in Uganda. Health Transit Rev 1995, 5(Suppl):201–208.
Gregson S, Anderson RM, Ndlovu J, et al.: Recent upturn in mortality in rural Zimbabwe: evidence for an early demographic impact of HIV-1 infection? AIDS 1997, 11:1269–1280.
Gregson S, Zhuwau T, Anderson RM, et al.: Age and religion selection biases in HIV-1 prevalence data from antenatal clinics in Manicaland, Zimbabwe. Cent Afr J Med 1995, 41:339–346.
Ntozi JPM, Nakanaabi IM, Lubaale YAM: Fertility levels and trends in the face of the AIDS epidemic in Uganda. Health Transit Rev 1997, 7(Suppl):145–155.
Porter L, Hao L, Bishai D, et al.: HIV status and union dissolution in sub-Saharan Africa: the case of Rakai, Uganda. Demography 2004, 41:465–482.
Pebley A, Mbugua W: Polygyny and fertility in sub-Saharan Africa. In Reproduction and Social Organization in Sub-Saharan Africa. Edited by Lesthaeghe RJ. Berkley, CA: University of California Press; 1989:338–364.
Larsen U: A comparative study of the levels and differentials of fertility in Cameroon, Kenya and Sudan. In Reproduction and Social Organization in Sub-Saharan Africa. Edited by Lesthaeghe RJ. Berkley, CA: University of California Press; 1989:167–206.
Arya OP, Nsanzumuhire H, Taber SR: Clinical, cultural, and demographic aspects of gonorrhoea in a rural community in Uganda. Bull World Health Organ 1973, 49:587–595.
Larsen U: Sterility in sub-Saharan Africa. Popul Stud 1994, 48:459–474.
Temmerman M, Plummer FA, Mirza NB, et al.: Infection with HIV as a risk factor for adverse obstetrical outcome. AIDS 1990, 4:1087–1093.
Leroy V, Ladner J, Nyiraziraje M, et al.: Effect of HIV-1 infection on pregnancy outcome in women in Kigali, Rwanda, 1992–1994. Pregnancy and HIV Study Group. AIDS 1998, 12:643–650.
Mayaud P, Mosha F, Todd J, et al.: Improved treatment services significantly reduce the prevalence of sexually transmitted diseases in rural Tanzania: results of a randomized controlled trial. AIDS 1997, 11:1873–1880.
Wawer MJ, Sewankambo NK, Serwadda D, et al.: Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 1999, 353:525–535.
Garnett GP, Swinton J, Brunham RC, Anderson RM: Gonococcal infection, infertility, and population growth: II. The influence of heterogeneity in sexual behaviour. IMA J Math Appl Med Biol 1992, 9:127–144.
Becker S, Rutstein S, Labbok MH: Estimation of births averted due to breast-feeding and increases in levels of contraception needed to substitute for breast-feeding. J Biosoc Sci 2003, 35:559–574.
Desgrees-du-Lou A, Brou H: Resumption of sexual relations following childbirth: norms, practices, and reproductive health issues in Abidjan, Cote d‘Ivoire. Reprod Health Matters 2005, 13:155–163.
Centers for Disease Control and Prevention: Family planning methods and practice: Africa, edn 2. Atlanta: United States Department of Health and Human Services; 2000.
Cleland JG, Ali MM, Capo-Chichi V: Post-partum sexual abstinence in West Africa: implications for AIDS-control and family planning programmes. AIDS 1999, 13:125–131.
Carael M, Cleland J, Deheneffe JC, Ferry B, Ingham R: Sexual behaviour in developing countries: implications for HIV control. AIDS 1995, 9:1171–1175.
Gaillard P, Folwer MG, Dabis F: Use of antiretroviral drugs to prevent HIV-1 transmission through breastfeeding: from animal studies to randomized clinical trials. J Acquir Defic Syndr 2004, 35:178–187.
Moatti JP, Prudhomme J, Traore DC, et al.: Access to antiretroviral treatment and sexual behaviours of HIV-infected patients aware of their serostatus in Cote d‘Ivoire. AIDS 2003, 17(Suppl 3):S69-S77.
Gray RH, Wawer MJ, Serwadda D, et al.: Population-based study of fertility in women with HIV-1 infection in Uganda. Lancet 1998, 351:98–103.
Widy-Wirski R, Berkley S, Downing R, et al.: Evaluation of the WHO clinical case definition for AIDS in Uganda. JAMA 1988, 260:3286–3289.
Chirgwin KD, Feldman J, Muneyyirci-Delale O, et al.: Menstrual function in human immunodeficiency virus-infected women without acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 12:489–494.
Krieger JN, Coombs RW, Collier AC, et al.: Fertility parameters in men infected with human immunodeficiency virus. J Infect Dis 1991, 164:464–469.
Martin PM, Gresenguet G, Herve VM, et al.: Decreased number of spermatozoa in HIV-1-infected individuals. AIDS 1992, 6:130.
Gray G, Bastos F, Andia I, et al.: Determinants of HAART use among women of reproductive age in Brazil, Uganda, and South Africa [abstract]. Paper presented at the XVI International AIDS Conference. Toronto; August 13–18, 2006.
Terceira N, Gregson S, Zaba B, Mason PR: The contribution of HIV to fertility decline in rural Zimbabwe, 1985–2000. Popul Stud 2003, 57:149–164.
Lutalo T, Kidugavu M, Wawer MJ, et al.: Trends and determinants of contraceptive use in Rakai District, Uganda, 1995–1998. Stud Fam Plann 2000, 31:217–227.
Okeibunor JC: Threat of AIDS and Condom Use in a Nigerian Urban Community: Implications for Fertility Regulation in Nigeria. Dakar, Senegal: Union for African Population Studies; 1999.
Glynn JR, Buve A, Carael M, et al.: Decreased fertility among HIV-1-infected women attending antenatal clinics in three African cities. J Acquir Immune Defic Syndr 2000, 25:345–352.
Rutenberg N, Biddlecom AE, Kaona AD: Reproductive decision-making in the context of HIV and AIDS: a qualitative study in Ndola, Zambia. Int Fam Plan Perspect 2000, 26:124–130.
Baylies C: The impact of HIV on family size preference in Zambia. Reprod Health Matters 2000, 8:77–86.
Panozzo L, Battegay M, Friedl A, et al.: High risk behaviour and fertility desires among heterosexual HIV-positive patients with a serodiscordant partner — two challenging issues. Swiss Med Wkly 2003, 133:124–127.
Brocklehurst P, French R: The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol 1998, 105:836–848.
Suy A, Martinez E, Coll O, et al.: Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS 2006, 20:59–66.
Tuomala RE, Shapiro DE, Mofenson LM, et al.: Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med 2002, 346:1863–1870.
Tuomala RE, Watts DH, Li D, et al.: Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy. J Acquir Immune Defic Syndr 2005, 38:449–473.
Thorne C, Newell ML: The safety of antiretroviral drugs in pregnancy. Expert Opin Drug Saf 2005, 4:323–335.
Desgrees-du-Lou A, Msellati P, Ramon R, et al.: HIV-1 infection and reproductive history: a retrospective study among pregnant women, Abidjan, Cote d‘Ivoire, 1995–1996. Ditrame Project. Int J STD AIDS 1998, 9:452–456.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaida, A., Andia, I., Maier, M. et al. The potential impact of antiretroviral therapy on fertility in sub-Saharan Africa. Curr HIV/AIDS Rep 3, 187–194 (2006). https://doi.org/10.1007/s11904-006-0015-0
Issue Date:
DOI: https://doi.org/10.1007/s11904-006-0015-0